Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 18/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22278557 | 1.00 | RORC (0.45) | RORCALDH1A1CYP1A2CYP3A4MAPT | |
| SCHEMBL24061256 | 1.00 | RORC (0.45) | RORCALDH1A1CYP1A2CYP3A4MAPT | |
| SCHEMBL30816134 | 1.00 | RORC (0.45) | RORCALDH1A1CYP1A2CYP3A4MAPT | |
| SCHEMBL22278565 | 0.89 | AKR1C3 (0.41) | RORCALDH1A1CYP1A2CYP3A4MAPT | |
| SCHEMBL29170641 | 0.88 | RORC (0.50) | RORCALDH1A1CYP1A2CYP3A4MAPT | |
| SCHEMBL29170646 | 0.88 | RORC (0.50) | RORCALDH1A1CYP1A2CYP3A4MAPT | |
| SCHEMBL23102328 | 0.87 | RORC (0.45) | RORC | |
| SCHEMBL30816096 | 0.87 | RORC (0.45) | RORC | |
| SCHEMBL23102318 | 0.87 | RORC (0.45) | RORC | |
| SCHEMBL23102331 | 0.86 | RORC (0.46) | RORCALDH1A1CYP1A2CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3915977-A1 | 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Abbisko Therapeutics Co., Ltd. (CN) | 2021-12-01 | — | — | EP | disclosed |
| WO-2021047406-A1 | TRICYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, PREPARATION METHOD THEREFOR AND USE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2021-03-18 | — | — | WO | disclosed |
| WO-2020151232-A1 | 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 上海和誉生物医药科技有限公司 | 2020-07-30 | — | — | WO | disclosed |